These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16435892)

  • 1. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line antiretroviral therapy for HIV-infected children.
    Terris-Prestholt F
    AIDS; 2015 Jun; 29(10):1261-2. PubMed ID: 26035324
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
    Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
    AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of antiretroviral therapy based on the 2015 WHO guidelines.
    Kuznik A; Iliyasu G; Habib AG; Musa BM; Kambugu A; Lamorde M
    AIDS; 2016 Nov; 30(18):2865-2873. PubMed ID: 27662547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of antiretrovirals - long term or short term?
    Flessa S
    Appl Health Econ Health Policy; 2009; 7(4):225-7. PubMed ID: 19905036
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost of antiretroviral drugs and influence on prescribing policies.
    Jones R; Gazzard B
    Int J STD AIDS; 2006 Aug; 17(8):499-506. PubMed ID: 16925892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Antiretroviral Therapy Costs in the United States, 2012-2018.
    McCann NC; Horn TH; Hyle EP; Walensky RP
    JAMA Intern Med; 2020 Apr; 180(4):601-603. PubMed ID: 32011622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theorising beyond the individual: adherence to antiretroviral therapy in resource-constrained societies.
    Kagee A; Swartz A; Swartz L
    J Health Psychol; 2014 Jan; 19(1):103-9. PubMed ID: 24058118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
    Long L; Fox M; Sanne I; Rosen S
    AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment French guidelines 2013: economics influencing science.
    Raffi F; Reynes J
    J Antimicrob Chemother; 2014 May; 69(5):1158-61. PubMed ID: 24443513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.
    Walensky RP; Ross EL; Kumarasamy N; Wood R; Noubary F; Paltiel AD; Nakamura YM; Godbole SV; Panchia R; Sanne I; Weinstein MC; Losina E; Mayer KH; Chen YQ; Wang L; McCauley M; Gamble T; Seage GR; Cohen MS; Freedberg KA
    N Engl J Med; 2013 Oct; 369(18):1715-25. PubMed ID: 24171517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic response among HIV-infected patients enrolled in a graduated cost-recovery programme of antiretroviral therapy delivery in Chennai, India.
    Solomon SS; Ganesh AK; Mehta SH; Yepthomi T; Balaji K; Anand S; Gallant JE; Solomon S
    Indian J Med Res; 2013 Jun; 137(6):1145-53. PubMed ID: 23852295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 18. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
    Gopalappa C; Stover J; Shaffer N; Mahy M
    AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.
    Kessler J; Braithwaite RS
    Curr Opin HIV AIDS; 2013 Nov; 8(6):544-9. PubMed ID: 24100874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing effectiveness and access to HIV treatment in the developing world.
    Hill A; Wood E
    AIDS; 2007 Jan; 21(3):361-3. PubMed ID: 17255743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.